143 related articles for article (PubMed ID: 215496)
1. Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis.
Johnson PJ; Krasner N; Portmann B; Eddleston AL; Williams R
Gut; 1978 Nov; 19(11):1022-6. PubMed ID: 215496
[TBL] [Abstract][Full Text] [Related]
2. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients.
Zaman SN; Melia WM; Johnson RD; Portmann BC; Johnson PJ; Williams R
Lancet; 1985 Jun; 1(8442):1357-60. PubMed ID: 2861313
[TBL] [Abstract][Full Text] [Related]
3. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS
J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399
[TBL] [Abstract][Full Text] [Related]
4. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of hepatocellular carcinoma in Shikoku, Japan: a study of 198 autopsy cases in Tokushima and Ehime Prefectures.
Akagi G; Furuya K; Otsuka H; Tao S; Moriwaki S
Jpn J Cancer Res; 1988 Jan; 79(1):25-31. PubMed ID: 2833481
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B surface antigen loss and clinical outcomes between HBeAg-negative cirrhosis patients who discontinued or continued nucleoside analogue therapy.
Hung CH; Wang JH; Lu SN; Hu TH; Lee CM; Chen CH
J Viral Hepat; 2017 Jul; 24(7):599-607. PubMed ID: 28130815
[TBL] [Abstract][Full Text] [Related]
7. Aetiology of cirrhosis, hepatic fibrosis, and hepatocellular carcinoma.
Blenkinsopp WK; Haffenden GP
J Clin Pathol; 1977 Jun; 30(6):579-84. PubMed ID: 194927
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B e antigen and the risk of hepatocellular carcinoma.
Yang HI; Lu SN; Liaw YF; You SL; Sun CA; Wang LY; Hsiao CK; Chen PJ; Chen DS; Chen CJ;
N Engl J Med; 2002 Jul; 347(3):168-74. PubMed ID: 12124405
[TBL] [Abstract][Full Text] [Related]
9. Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
Yip TC; Chan HL; Wong VW; Tse YK; Lam KL; Wong GL
J Hepatol; 2017 Nov; 67(5):902-908. PubMed ID: 28652084
[TBL] [Abstract][Full Text] [Related]
10. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
Jee SH; Ohrr H; Sull JW; Samet JM
J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in immigrants to the United Kingdom.
Zaman SN; Johnson PJ; Williams R
Q J Med; 1986 Aug; 60(232):813-7. PubMed ID: 3022324
[TBL] [Abstract][Full Text] [Related]
12. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
Gastroenterology; 2012 May; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
15. Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance.
Liu F; Wang XW; Chen L; Hu P; Ren H; Hu HD
Aliment Pharmacol Ther; 2016 Jun; 43(12):1253-61. PubMed ID: 27117732
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of hepatocellular carcinoma.
Rustgi VK
Gastroenterol Clin North Am; 1987 Dec; 16(4):545-51. PubMed ID: 2831148
[TBL] [Abstract][Full Text] [Related]
17. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
Shimada S; Aizawa R; Abe H; Suto S; Miyakawa Y; Aizawa Y
Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
[TBL] [Abstract][Full Text] [Related]
18. Relative incidence of primary liver cancer in cirrhosis in Austria. Etiological considerations.
Ferenci P; Dragosics B; Marosi L; Kiss F
Liver; 1984 Feb; 4(1):7-14. PubMed ID: 6321878
[TBL] [Abstract][Full Text] [Related]
19. [Primary hepatocarcinoma. Epidemiologic case-control study in the province of Bergamo].
Colloredo Mels G; Paris B; Bertone V; Angeli G
Minerva Med; 1986 Mar; 77(9-10):297-306. PubMed ID: 3005920
[TBL] [Abstract][Full Text] [Related]
20. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
